Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $13.7 Million - $18.8 Million
-50,000 Closed
0 $0
Q3 2019

Feb 12, 2021

BUY
$273.46 - $318.39 $13.5 Million - $15.8 Million
49,500 Added 9900.0%
50,000 $13.9 Million
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $136,730 - $159,195
500 New
500 $120,000
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $3.36 Million - $4.03 Million
-10,000 Closed
0 $0
Q3 2018

Feb 11, 2021

BUY
$351.14 - $408.51 $3.48 Million - $4.04 Million
9,900 Added 9900.0%
10,000 $4.04 Million
Q3 2018

Nov 14, 2018

BUY
$351.14 - $408.51 $35,114 - $40,851
100 New
100 $201,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.